Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 148403, 10 pages
http://dx.doi.org/10.1155/2012/148403
Research Article

Evidence for Inhibitory Effects of Flupirtine, a Centrally Acting Analgesic, on Delayed Rectifier K+ Currents in Motor Neuron-Like Cells

1Department of Physiology, National Cheng Kung University Medical College, Tainan City 70101, Taiwan
2Institute of Basic Medical Sciences, National Cheng Kung University Medical College, Tainan City 70101, Taiwan
3Department of Psychology, National Cheng Kung University, Tainan City 70101, Taiwan
4Department of Pediatrics, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan
5Department of Pharmacology, Kaohsiung Medical University, Kaohsiung City 80708, Taiwan

Received 10 May 2012; Accepted 18 June 2012

Academic Editor: Adair Roberto Soares Santos

Copyright © 2012 Sheng-Nan Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Harish, K. Bhuvana, G. M. Bengalorkar, and T. Kumar, “Flupirtine: clinical pharmacology,” Journal of Anaesthesiology Clinical Pharmacology, vol. 28, no. 2, pp. 172–177, 2012. View at Google Scholar
  2. M. Otto, L. Cepek, P. Ratzka et al., “Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study,” Neurology, vol. 62, no. 5, pp. 714–718, 2004. View at Google Scholar · View at Scopus
  3. B. S. Appleby and C. G. Lyketsos, “Rapidly progressive dementias and the treatment of human prion diseases,” Expert Opinion on Pharmacotherapy, vol. 12, no. 1, pp. 1–12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. T. R. Su, W. S. Zei, C. C. Su, G. Hsiao, and M. J. Lin, “The effects of the KCNQ openers retigabine and flupirtine on myotonia in mammalian skeletal muscle induced by a chloride channel blocker,” Evidence-Based Complement and Alternative Medicine, vol. 2012, Article ID 803082, 9 pages, 2012. View at Publisher · View at Google Scholar
  5. M. Schwarz, F. Block, and G. Pergande, “N-methyl-D-aspartate (NMDA)-mediated muscle relaxant action of flupirtine in rats,” NeuroReport, vol. 5, no. 15, pp. 1981–1984, 1994. View at Google Scholar · View at Scopus
  6. N. N. Osborne, C. Cazevieille, J. P. M. Wood et al., “Flupirtine, a nonopioid centrally acting analgesic, acts as an NMDA antagonist,” General Pharmacology, vol. 30, no. 3, pp. 255–263, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Klinger, P. Geier, M. M. Dorostkar et al., “Concomitant facilitation of GABAA receptors and Kv7 channels by the non-opioid analgesic flupirtine,” British Journal of Pharmacology, vol. 166, no. 5, pp. 1631–1642, 2011. View at Google Scholar
  8. H. Chen, B. S. Jassar, D. E. Kurenny, and P. A. Smith, “Phorbol ester-induced M-current suppression in bull-frog sympathetic ganglion cells: insensitivity to kinase inhibitors,” British Journal of Pharmacology, vol. 113, no. 1, pp. 55–62, 1994. View at Google Scholar · View at Scopus
  9. Q. Xiong, Z. Gao, W. Wang, and M. Li, “Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds,” Trends in Pharmacological Sciences, vol. 29, no. 2, pp. 99–107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. D. A. Brown and G. M. Passmore, “Neural KCNQ (Kv7) channels,” British Journal of Pharmacology, vol. 156, no. 8, pp. 1185–1195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Maljevic, T. V. Wuttke, and H. Lerche, “Nervous system KV7 disorders: breakdown of a subthreshold brake,” Journal of Physiology, vol. 586, no. 7, pp. 1791–1801, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Ryu, G. S. Jeon, N. R. Cashman, N. W. Kowall, and J. Lee, “Differential expression of c-Ret in motor neurons versus non-neuronal cells is linked to the pathogenesis of ALS,” Laboratory Investigation, vol. 91, no. 3, pp. 342–352, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Y. Hsu, C. S. Chen, S. N. Wu, Y. J. Jong, and Y. C. Lo, “Berberine activates Nef2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor neuron-like cells,” European Journal of Pharmaceutical Sciences, vol. 46, no. 5, pp. 415–425, 2012. View at Google Scholar
  14. S. N. Wu, C. C. Yeh, H. C. Huang, E. C. So, and Y. C. Lo, “Electrophysiological characterization of sodium-activated potassium channels in NG108-15 and NSC-34 motor neuron-like cells,” Acta Physiologica, 2012. In press. View at Publisher · View at Google Scholar
  15. C. W. Huang, C. C. Huang, M. W. Lin, J. J. Tsai, and S. N. Wu, “The synergistic inhibitory actions of oxcarbazepine on voltage-gated sodium and potassium currents in differentiated NG108-15 neuronal cells and model neurons,” International Journal of Neuropsychopharmacology, vol. 11, no. 5, pp. 597–610, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. W. Lin, Y. J. Wang, S. I. Liu, A. A. Lin, Y. C. Lo, and S. N. Wu, “Characterization of aconitine-induced block of delayed rectifier k+ current in differentiated NG108-15 neuronal cells,” Neuropharmacology, vol. 54, no. 6, pp. 912–923, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. N. Wu, Y. Lo, H. Chen, H. F. Li, and H. T. Chiang, “Rutaecarpine-induced block of delayed rectifier k+ current in NG108-15 neuronal cells,” Neuropharmacology, vol. 41, no. 7, pp. 834–843, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Mishra, P. Choudhary, S. Joshi, and S. Bhatnagar, “Successful use of flupirtine in refractory neuropathic pain due to small fiber neuropathy,” American Journal of Hospice & Palliative Medicine. In press.
  19. H. Meves, J. R. Schwarz, and I. Wulfsen, “Separation of M-like current and ERG current in NG108-15 cells,” British Journal of Pharmacology, vol. 127, no. 5, pp. 1213–1223, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Peretz, N. Degani, R. Nachman et al., “Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties,” Molecular Pharmacology, vol. 67, no. 4, pp. 1053–1066, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Y. Wang, L. Gan, I. D. Forsythe, and L. K. Kaczmarek, “Contribution of the Kv3.1 potassium channel to high frequency firing in mouse auditory neurones,” Journal of Physiology, vol. 509, no. 1, pp. 183–194, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Miceli, M. V. Soldovieri, M. Martire, and M. Taglialatela, “Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs,” Current Opinion in Pharmacology, vol. 8, no. 1, pp. 65–74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. N. Wu, B. S. Chen, M. W. Lin, and Y. C. Liu, “Contribution of slowly inactivating potassium current to delayed firing of action potentials in NG108-15 neuronal cells: experimental and theoretical studies,” Journal of Theoretical Biology, vol. 252, no. 4, pp. 711–721, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. E. Sander, C. Lemm, N. Lange, M. Hamann, and A. Richter, “Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates L-DOPA-induced dyskinesias in 6-OHDA-lesioned rats,” Neuropharmacology, vol. 62, no. 2, pp. 1052–1061, 2012. View at Google Scholar
  25. W. E. G. Müller, F. J. Romero, S. Perovic, G. Pergande, and P. Pialoglou, “Protection of flupirtine on β-amyloid-induced apoptosis in neuronal cells in vitro: prevention of amyloid-induced glutathione depletion,” Journal of Neurochemistry, vol. 68, no. 6, pp. 2372–2377, 1997. View at Google Scholar · View at Scopus
  26. W. E. G. Müller, J. L. Laplanche, H. Ushijima, and H. C. Schröder, “Novel approaches in diagnosis and therapy of Creutzfeldt-Jakob disease,” Mechanisms of Ageing and Development, vol. 116, no. 2-3, pp. 193–218, 2000. View at Publisher · View at Google Scholar · View at Scopus